Full Sail Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Full Sail Capital's BMY Position: Q3 2025 in Review
Full Sail Capital opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 5,585 shares worth $252K. The stake represents 0.01% of the portfolio and ranks #263 among its holdings. This is a return to the name: Full Sail Capital previously reported a position in BMY as recently as Q3 2023.
Full Sail Capital first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. The position peaked at $389K in Q4 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Full Sail Capital held 5,585 shares of Bristol-Myers Squibb worth $252K as of Q3 2025.
- Bristol-Myers Squibb was a new Full Sail Capital position in Q3 2025.
- Bristol-Myers Squibb made up 0.01% of Full Sail Capital's portfolio in Q3 2025, its #263 holding.
- Full Sail Capital first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
- Full Sail Capital's Bristol-Myers Squibb position peaked at $389K in Q4 2019.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Full Sail Capital's 13F filing for Q3 2025, filed 14 Nov 2025.